Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Dose Safety, Tolerability, Plasma and Cerebrospinal-Fluid Pharmacokinetic Study of Oral Doses of CORT113176

NCT04994743 is registered in ClinicalTrials.gov with Corcept Therapeutics as lead sponsor.

NCT NCT04994743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04994743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Dose Safety, Tolerability, Plasma and Cerebrospinal-Fluid Pharmacokinetic Study of Oral Doses of CORT113176
Lead sponsor
Corcept Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
July 13, 2021
Completion date
September 30, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adults